Longbow Research Upgrades Psychiatric Solutions (PSYS) to Buy
More News related to PSYS
- Psychiatric Solutions Completes $70 Million Sale of EAP Business to Aetna
- Raymond James Downgrades Psychiatric Solutions (PSYS) From Strong Buy To Market Perform
- Unusual 11 Mid-Day Movers 10/28: CTS, QTM, KWR, CIT, NTRI Higher; KSP, CALC, PSYS, ILMN Lower
- Dyer & Berens LLP Announces November 20, 2009 Lead Plaintiff Deadline in Class Action Lawsuit Filed on Behalf of Certain Investors Who Purchased or Acquired Psychiatric Solutions, Inc. Common Stoc
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
Longbow Research upgrades Psychiatric Solutions (Nasdaq: PSYS) from Neutral to Buy. Price target $35.
Psychiatric Solutions, Inc. (Psychiatric Solutions), is a provider of inpatient behavioral healthcare services in the United States.
To see more analyst ratings on PSYS Click Here.
Related Categories
UpgradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
